个体化营养远程护理降低美国患者肝脏相关事件风险
本研究基于Komodo医疗地图数据,将2015-2024年参与个体化营养远程护理(VINT)的2型糖尿病、糖尿病前期、超重或肥胖成人按1:1匹配至常规护理组(每组n=5031),评估新发MASLD、MASH及晚期肝病风险。结果显示VINT组肝脏相关诊断、MASH及以上、晚期肝病及肝脏并发症发生率均显著低于常规护理组。
要点
- 体重减轻≥15%者新发肝病风险低于减重不足者(HR=0.66)。
核心结论
- 参与以个体化营养为重点的远程医疗护理与2型糖尿病和肥胖成人新发MASLD、MASH及晚期肝病的发生率和风险显著降低相关。
研究设计与样本
- 研究基于Komodo医疗地图识别2015-2024年参与VINT的2型糖尿病、糖尿病前期、超重或肥胖成人,并按1:1匹配至常规护理对照组(每组n=5031)。
- 采用3种互补分析方法进行新发肝病的发病率与时间-事件分析。
主要发现
- VINT组任何肝脏相关诊断发生率为27.3 vs 42.8/1000人年(HR=0.61,p<0.001)。
- VINT组MASH及以上发生率为4.2 vs 10.7/1000人年(HR=0.38,p<0.001)。
- VINT组晚期肝病发生率为2.8 vs 8.7/1000人年(HR=0.33,p<0.001)。
- VINT组任何肝脏并发症发生率为2.0 vs 7.7/1000人年(HR=0.25,p<0.001)。
- VINT参与者中体重减轻≥15%者新发肝病风险低于减重不足者(21.2 vs 31.8/1000人年;HR=0.66,p=0.02)。
临床怎么用
- 对2型糖尿病和肥胖成人,可考虑将个体化营养远程护理作为生活方式优先的干预策略以降低肝病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), can lead to significant morbidity and mortality in adults with type 2 diabetes (T2D) and obesity. This study evaluated whether participation in an individualized, nutrition-focused telemedicine care model emphasizing carbohydrate reduction (Virta Individualized Nutrition Therapy, VINT) was associated with reduced onset of MASLD, MASH, and advanced liver disease. APPROACH AND RESULTS: Adults with T2D, prediabetes, overweight,or obesity who enrolled in VINT (2015-2024) were identified in the Komodo Healthcare Map and matched 1:1 to usual care (UC) controls (n=5031 per group). Using 3 complementary analytic approaches, incidence and time-to-event analyses were performed for new-onset liver disease. Across all strategies, VINT participants consistently showed a lower incidence of any liver-related diagnosis (27.3 vs. 42.8 per 1000 person-years; HR=0.61, p <0.001), MASH-and-beyond (4.2 vs. 10.7; HR=0.38, p <0.001), advanced liver disease (2.8 vs. 8.7; HR=0.33, p <0.001), and any liver complications (2.0 vs. 7.7; HR=0.25, p <0.001). VINT participants who lost ≥15% body weight were at lower risk of new-onset liver disease (21.2 vs. 31.8 per 1000 person-years; HR=0.66, p =0.02) compared with VINT participants who lost less weight. CONCLUSIONS: Participation in individualized nutrition-focused telemedicine care was associated with significantly lower incidence and risk of new-onset MASLD, MASH, and advanced liver disease. These findings support lifestyle-first interventions that are potentially scalable to reduce liver disease burden in adults with T2D and obesity.
引用
- Athinarayanan SJ, Wolfberg AJ, Shanmugam PV, et al. Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States. Hepatology. 2026. PMID: 41842839. doi:10.1097/HEP.0000000000001713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。